ArticleJournal of innate immunity2026
Neutrophil Killing of
Article in Journal of innate immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDysregulated neutrophil functions play a crucial role in the onset and progression of periodontitis. Peptoanaerobacter stomatis is an emerging oral bacterium associated with periodontitis and is known to activate neutrophils through TLR2/6, leading to ROS production, granule release, and neutrophil extracellular trap (NET) formation. In this study, we characterized MAPK kinases that regulate these neutrophil responses and determined the mechanism responsible for bacterial killing.
methodsHuman neutrophils were challenged with P. stomatis, and kinase activation was assessed by immunoblot. Functional relevance was tested using selective kinase inhibitors prior to bacterial exposure. Neutrophil responses measured included ROS production by kinetic fluorometric assay, degranulation by flow cytometry, and NET formation using immunofluorescence and immunoblotting. Bacterial killing was determined by a CFU assay.
resultsP. stomatis activated ERK and p38 MAPKs, PI3K/AKT, and Src and Syk tyrosine kinases in neutrophils. Inhibition of all kinases except AKT significantly reduced ROS production. Because TAK1 is an upstream regulator of MAPK signaling, its role was also evaluated. Degranulation was mainly regulated by TAK1 and p38, with partial involvement of ERK and Src. NET formation required TAK1, ROS, and PAD4. TAK1 and degranulation inhibition markedly decreased bacterial killing, whereas inhibition of ROS or NET had no effect.
conclusionThese findings demonstrate that although P. stomatis evades ROS- and NET-mediated killing, it remains susceptible to TAK1-mediated neutrophil degranulation, identifying degranulation as the primary mechanism for bacterial clearance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.